Pure Appl. Chem., 2003, Vol. 75, No. 11-12, pp. 1917-1932
http://dx.doi.org/10.1351/pac200375111917
Role of metabolism in the endocrine-disrupting effects of chemicals in aquatic and terrestrial systems
Abstract:
This review describes the role of metabolism with
endocrine active substances. Many modern synthetic compounds are readily
metabolized to more polar forms that often contain hydroxy groups. This
presence of polar groups and aromatic moieties in the parent compound
or metabolite can play an important role in the mechanism of endocrine
disruption. In addition, phase II metabolism (e.g., glucuronidation)
can also lead to deactivation of the endocrine properties. In the case
of bisphenol A and alkylphenols, metabolism can be considered as a detoxification
mechanism as glucuronides decrease of inhibit binding to the estrogen
receptors. In the case of phthalate esters, the primary metabolites,
the monoesters, and further degraded metabolites do not interact with
the estrogen receptor either. In contrast, the demethylation of methoxychlor
in fish and other vertebrate species leads to metabolites with an increased
affinity for the estrogen receptor. Certain PCB metabolites with hydroxy
groups on the para position without vicinal chlorines have estrogenic
activity, but these metabolites are not relevant for the environment.
PCB metabolites with methylsulfonyl groups are commonly found in environmental
biota and have been associated with several endocrine, developmental,
and reproductive effects. Some DDT metabolites bind weakly to the estrogen
receptor, but the major biotransformation product p,p-DDE is
an androgen receptor (AR) antagonist. Vinclozolin is an anti-androgen
and this effect appears to caused by two of its more water-soluble metabolites.
The chloro-s-triazines exhibit an in vitro induction of aromatase,
but their dealkylated metabolites show a decrease or lack of this effect.
It is recognized that common metabolic processes can differ strongly
among species that complicates ecotoxicological risk assessment of endocrine
active substances. In conclusion, the testing of metabolites for endocrine-disrupting
properties should be encouraged in the future to establish a better
risk assessment process.
An appendix containing levels and half-lives of various endocrine-disrupting
chemicals in the environment and in wildlife is included at the end
of this article.